vs

Side-by-side financial comparison of CABOT CORP (CBT) and DELUXE CORP (DLX). Click either name above to swap in a different company.

CABOT CORP is the larger business by last-quarter revenue ($849.0M vs $535.2M, roughly 1.6× DELUXE CORP). CABOT CORP runs the higher net margin — 8.6% vs 2.2%, a 6.4% gap on every dollar of revenue. On growth, DELUXE CORP posted the faster year-over-year revenue change (2.8% vs -11.1%). Over the past eight quarters, DELUXE CORP's revenue compounded faster (0.0% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

Deluxe Corporation is an American company that provides payment processing, data services, checks and promotional products, and merchant services. It operates in four divisions: B2B payments, data, print, and merchant services. As of 2025, the company serves millions of small businesses and thousands of financial institutions, processing more than $2.8 trillion in payments annually. While its legacy business centers on check printing and other printed products, payments and data services now ...

CBT vs DLX — Head-to-Head

Bigger by revenue
CBT
CBT
1.6× larger
CBT
$849.0M
$535.2M
DLX
Growing faster (revenue YoY)
DLX
DLX
+13.9% gap
DLX
2.8%
-11.1%
CBT
Higher net margin
CBT
CBT
6.4% more per $
CBT
8.6%
2.2%
DLX
Faster 2-yr revenue CAGR
DLX
DLX
Annualised
DLX
0.0%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBT
CBT
DLX
DLX
Revenue
$849.0M
$535.2M
Net Profit
$73.0M
$12.0M
Gross Margin
24.9%
52.2%
Operating Margin
15.2%
8.9%
Net Margin
8.6%
2.2%
Revenue YoY
-11.1%
2.8%
Net Profit YoY
-21.5%
-5.0%
EPS (diluted)
$1.37
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
DLX
DLX
Q4 25
$849.0M
$535.2M
Q3 25
$899.0M
$540.2M
Q2 25
$923.0M
$521.3M
Q1 25
$936.0M
$536.5M
Q4 24
$955.0M
$520.6M
Q3 24
$1.0B
$528.4M
Q2 24
$1.0B
$537.8M
Q1 24
$1.0B
$535.0M
Net Profit
CBT
CBT
DLX
DLX
Q4 25
$73.0M
$12.0M
Q3 25
$43.0M
$33.7M
Q2 25
$101.0M
$22.4M
Q1 25
$94.0M
$14.0M
Q4 24
$93.0M
$12.6M
Q3 24
$137.0M
$8.9M
Q2 24
$109.0M
$20.5M
Q1 24
$84.0M
$10.8M
Gross Margin
CBT
CBT
DLX
DLX
Q4 25
24.9%
52.2%
Q3 25
24.5%
53.9%
Q2 25
26.4%
53.6%
Q1 25
25.7%
52.4%
Q4 24
24.6%
52.3%
Q3 24
24.0%
53.3%
Q2 24
25.2%
53.7%
Q1 24
24.1%
53.0%
Operating Margin
CBT
CBT
DLX
DLX
Q4 25
15.2%
8.9%
Q3 25
15.2%
14.0%
Q2 25
18.1%
11.7%
Q1 25
17.3%
9.0%
Q4 24
16.2%
9.0%
Q3 24
15.0%
7.9%
Q2 24
16.9%
11.0%
Q1 24
15.3%
8.3%
Net Margin
CBT
CBT
DLX
DLX
Q4 25
8.6%
2.2%
Q3 25
4.8%
6.2%
Q2 25
10.9%
4.3%
Q1 25
10.0%
2.6%
Q4 24
9.7%
2.4%
Q3 24
13.7%
1.7%
Q2 24
10.7%
3.8%
Q1 24
8.2%
2.0%
EPS (diluted)
CBT
CBT
DLX
DLX
Q4 25
$1.37
$0.25
Q3 25
$0.80
$0.74
Q2 25
$1.86
$0.50
Q1 25
$1.69
$0.31
Q4 24
$1.67
$0.28
Q3 24
$2.41
$0.20
Q2 24
$1.94
$0.46
Q1 24
$1.49
$0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
DLX
DLX
Cash + ST InvestmentsLiquidity on hand
$230.0M
$36.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.6B
$680.7M
Total Assets
$3.8B
$2.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
DLX
DLX
Q4 25
$230.0M
$36.9M
Q3 25
$258.0M
$25.8M
Q2 25
$239.0M
$26.0M
Q1 25
$213.0M
$30.3M
Q4 24
$183.0M
$34.4M
Q3 24
$223.0M
$41.3M
Q2 24
$197.0M
$23.1M
Q1 24
$206.0M
$23.5M
Total Debt
CBT
CBT
DLX
DLX
Q4 25
Q3 25
$1.1B
Q2 25
Q1 25
Q4 24
Q3 24
$1.1B
Q2 24
Q1 24
Stockholders' Equity
CBT
CBT
DLX
DLX
Q4 25
$1.6B
$680.7M
Q3 25
$1.6B
$664.1M
Q2 25
$1.5B
$638.7M
Q1 25
$1.4B
$622.5M
Q4 24
$1.4B
$620.9M
Q3 24
$1.4B
$612.7M
Q2 24
$1.3B
$620.5M
Q1 24
$1.4B
$608.4M
Total Assets
CBT
CBT
DLX
DLX
Q4 25
$3.8B
$2.9B
Q3 25
$3.8B
$2.6B
Q2 25
$3.8B
$2.5B
Q1 25
$3.8B
$2.6B
Q4 24
$3.6B
$2.8B
Q3 24
$3.7B
$2.6B
Q2 24
$3.6B
$2.7B
Q1 24
$3.6B
$2.7B
Debt / Equity
CBT
CBT
DLX
DLX
Q4 25
Q3 25
0.70×
Q2 25
Q1 25
Q4 24
Q3 24
0.75×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
DLX
DLX
Operating Cash FlowLast quarter
$126.0M
$102.1M
Free Cash FlowOCF − Capex
$57.0M
FCF MarginFCF / Revenue
6.7%
Capex IntensityCapex / Revenue
8.1%
Cash ConversionOCF / Net Profit
1.73×
8.53×
TTM Free Cash FlowTrailing 4 quarters
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
DLX
DLX
Q4 25
$126.0M
$102.1M
Q3 25
$219.0M
$67.1M
Q2 25
$249.0M
$51.1M
Q1 25
$73.0M
$50.3M
Q4 24
$124.0M
$60.2M
Q3 24
$204.0M
$67.9M
Q2 24
$207.0M
$39.6M
Q1 24
$176.0M
$26.6M
Free Cash Flow
CBT
CBT
DLX
DLX
Q4 25
$57.0M
Q3 25
$155.0M
Q2 25
$188.0M
$27.8M
Q1 25
$1.0M
$24.3M
Q4 24
$47.0M
Q3 24
$112.0M
$46.7M
Q2 24
$155.0M
$11.4M
Q1 24
$133.0M
$6.1M
FCF Margin
CBT
CBT
DLX
DLX
Q4 25
6.7%
Q3 25
17.2%
Q2 25
20.4%
5.3%
Q1 25
0.1%
4.5%
Q4 24
4.9%
Q3 24
11.2%
8.8%
Q2 24
15.3%
2.1%
Q1 24
13.1%
1.1%
Capex Intensity
CBT
CBT
DLX
DLX
Q4 25
8.1%
Q3 25
7.1%
Q2 25
6.6%
4.5%
Q1 25
7.7%
4.8%
Q4 24
8.1%
Q3 24
9.2%
4.0%
Q2 24
5.1%
5.2%
Q1 24
4.2%
3.8%
Cash Conversion
CBT
CBT
DLX
DLX
Q4 25
1.73×
8.53×
Q3 25
5.09×
1.99×
Q2 25
2.47×
2.28×
Q1 25
0.78×
3.59×
Q4 24
1.33×
4.77×
Q3 24
1.49×
7.60×
Q2 24
1.90×
1.94×
Q1 24
2.10×
2.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

DLX
DLX

Services$247.9M46%
B2B Payments$76.3M14%
Datadrivenmarketingsolutions$68.5M13%
Promotional Solutions Revenue$60.9M11%
Treasurymanagementsolutions$59.8M11%
Other$17.3M3%
Other Web Based Solutions$4.6M1%

Related Comparisons